Physician

Aditya V. Shreenivas, MD

According to 2025 Medicare claims, Aditya Shreenivas, MD (NPI: 1215282264) practices medical oncology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL FOUNDATION (NPI: 1871886366; TIN: 274803222) and primary practice location at 91010-3012.

Shreenivas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 94 traditional Medicare patients, billed 213 HCPCS/CPT codes, and received $18,714 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 210 prescription claims across 57 beneficiaries totaling $653,198 in drug costs, led by Mekinist (Trametinib Dimethyl Sulfoxide). Open Payments data shows 7 records totaling $68,424. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $15,515 to $653,198. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$42K2019 Medicare payment: $11,610 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $28,662 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $41,638 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $40,249 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $23,484 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $18,714 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201931130$11,610
202073319$28,662
202190423$41,638
202274461$40,249
202384310$23,484
202494213$18,714

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$371K$742K2015 Drug cost: $15,515 (USD; Tot_Drug_Cst)2016 Drug cost: $40,925 (USD; Tot_Drug_Cst)2017 Drug cost: $21,088 (USD; Tot_Drug_Cst)2019 Drug cost: $9,387 (USD; Tot_Drug_Cst)2020 Drug cost: $259,628 (USD; Tot_Drug_Cst)2021 Drug cost: $121,344 (USD; Tot_Drug_Cst)2022 Drug cost: $280,203 (USD; Tot_Drug_Cst)2023 Drug cost: $742,015 (USD; Tot_Drug_Cst)2024 Drug cost: $653,198 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201528133$15,515
20163054$40,925
2017N/R17$21,088
2018N/RN/RN/R
201925117$9,387
202056365$259,628
202178434$121,344
202272339$280,203
202357219$742,015
202457210$653,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more3030$154
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more1922$120
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5587$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2046$56

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MekinistTrametinib Dimethyl Sulfoxide15450$141,369
Prochlorperazine MaleateProchlorperazine Maleate26301$345
DexamethasoneDexamethasone14226$334
Ondansetron HclOndansetron Hcl21215$218

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$130Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.1$68,294Merck Sharp & Dohme LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aditya V. Shreenivas, MD?

Tedicare shows public-source Medicare data for Aditya V. Shreenivas, MD (NPI 1215282264), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditya V. Shreenivas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aditya V. Shreenivas, MD?

Aditya V. Shreenivas, MD is linked to CITY OF HOPE MEDICAL FOUNDATION (billing NPI 1871886366) in the available physician profile data.

Does Aditya V. Shreenivas, MD have Open Payments data?

Aditya V. Shreenivas, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.